Management of chronic pain in the elderly: focus on transdermal buprenorphine.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 2682375)

Published in Clin Interv Aging on January 01, 2008

Authors

Nalini Vadivelu1, Roberta L Hines

Author Affiliations

1: Department of Anesthesiology,Yale University School of Medicine, New Haven 06520, USA. nalini.vadivelu@yale.edu

Articles cited by this

Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54

Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med (2003) 3.82

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry (1978) 3.33

Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther (1994) 2.90

Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology (2000) 2.82

Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain (2005) 2.42

Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain (2003) 2.18

The prevalence of pain complaints in a general population. Pain (1984) 2.13

Opioids and chronic neuropathic pain. N Engl J Med (2003) 1.83

Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther (1995) 1.73

Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain (1995) 1.63

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet (2000) 1.55

The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos (1985) 1.49

The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population. Eur J Pain (1999) 1.46

Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth (2005) 1.44

Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth (2006) 1.41

Buprenorphine: considerations for pain management. J Pain Symptom Manage (2005) 1.40

Chronic pain in elderly people. Pain (1997) 1.35

Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs (1979) 1.32

The use of oral opioids in patients with chronic non-cancer pain. Management strategies. Med J Aust (1997) 1.26

Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther (2003) 1.23

Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport (2003) 1.21

Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology (2003) 1.18

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett (1995) 1.17

Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? J Pharmacol Exp Ther (2000) 1.13

The relationships among anxiety, depression, and pain in a geriatric institutionalized sample. Pain (1995) 1.12

Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain (1998) 1.11

Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor. Peptides (2000) 1.11

Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Psychopharmacology (Berl) (2002) 1.09

Demographics, assessment and management of pain in the elderly. Drugs Aging (2003) 1.09

Musculoskeletal complaints and associated consequences in elderly Chinese aged 70 years and over. J Rheumatol (1994) 1.07

Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients. Pain Pract (2007) 1.06

Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics. J Pharmacol Exp Ther (2005) 1.05

Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin (2005) 1.01

Transdermal buprenorphine. Drugs (2003) 1.00

Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J Pharmacol Exp Ther (1997) 0.96

Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine. Eur J Pain (2006) 0.96

Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther (2004) 0.95

Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology (2000) 0.95

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine. Biol Pharm Bull (2002) 0.95

Six deaths linked to misuse of buprenorphine-benzodiazepine combinations. Am J Psychiatry (1998) 0.95

No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters. Clin Immunol (2003) 0.94

Transdermal treatment options for neurological disorders: impact on the elderly. Drugs Aging (2006) 0.93

A double blind comparison of buprenorphine and morphine in conscious subjects following administration by the intramuscular route. Acta Anaesthesiol Belg (1976) 0.92

Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther (2005) 0.90

Buprenorphine: a unique opioid with broad clinical applications. J Opioid Manag (2007) 0.88

Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites. Br J Anaesth (1990) 0.87

A new series of 13 buprenorphine-related deaths. Clin Biochem (2002) 0.86

Naloxone reversal of buprenorphine-induced respiratory depression. Clin Pharmacol Ther (1989) 0.86

Early respiratory depression resistant to naloxone following epidural buprenorphine. Anesthesiology (1986) 0.85

Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. Br J Anaesth (1998) 0.84

The regulation of transplacental cortisol-cortisone metabolism by estrogen in pregnant baboons. Endocrinology (1988) 0.84

Buprenorphine-associated deaths in Singapore. Ann Acad Med Singapore (2006) 0.84

Opioids: from analgesia to anti-hyperalgesia? Pain (2005) 0.84

Buprenorphine in long-term control of chronic pain in cancer patients. Front Biosci (2007) 0.84

Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry (2007) 0.83

Buprenorphine in a transdermal therapeutic system--a new option. Clin Rheumatol (2002) 0.83

Effect of buprenorphine on CYP3A activity in rat and human liver microsomes. Life Sci (2000) 0.83

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine. Fundam Clin Pharmacol (1998) 0.83

Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. Clin Ther (2005) 0.83

Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther (2006) 0.83

Biliary excretion, metabolism and enterohepatic circulation of buprenorphine. Xenobiotica (1981) 0.82

Improvement in postoperative pain relief by the addition of midazolam to an intrathecal injection of buprenorphine and bupivacaine. Eur J Anaesthesiol (2003) 0.82

Transdermal buprenorphine in cancer pain and palliative care. Palliat Med (2006) 0.82

Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury. Eur J Pharmacol (2002) 0.82

Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. Clin Ther (2006) 0.81

Neuropathic pain: evidence matters. Eur J Pain (2002) 0.81

Percutaneous absorption of sunscreen agents from liquid paraffin: self-association of octyl salicylate and effects on skin flux. J Pharm Sci (1997) 0.81

Buprenorphine and the transdermal system: the ideal match in pain management. Int J Clin Pract Suppl (2003) 0.80

Old dog--new (ma)trix. Br J Anaesth (2003) 0.80

Can psychometric tools be used to analyse pain in a geriatric population? Clin Exp Neurol (1989) 0.80

Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal gray. Zhongguo Yao Li Xue Bao (1998) 0.79

Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers. Eur J Clin Pharmacol (2007) 0.79

Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies. Anesth Analg (2005) 0.79

Tramadol-benzodiazepines and buprenorphine-benzodiazepines: two potentially fatal cocktails? J Clin Forensic Med (2003) 0.79

Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control. Curr Med Res Opin (2004) 0.78

Advances in pain management for older adult patients. Clin Geriatr Med (2000) 0.78

Intrathecal buprenorphine in the treatment of phantom limb pain. Anesth Analg (1995) 0.77

Buprenorphine in end stage renal failure. Anaesthesia (1985) 0.76

Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocine. Arzneimittelforschung (1983) 0.76

Individual choice of opioids and formulations: strategies to achieve the optimum for the patient. Clin Rheumatol (2002) 0.76

Epidural buprenorphine. How safe is "safe". Acta Anaesthesiol Scand (1994) 0.76

Buprenorphine treatment of patients with non-malignant musculoskeletal diseases. Clin Rheumatol (2002) 0.76

Back pain in the elderly: updated diagnosis and management. Geriatrics (1986) 0.76

Principles of geriatric pharmacology. J Indian Med Assoc (2007) 0.76

[Old age and the kidneys]. Orv Hetil (2008) 0.76

Dementia presenting with sore eyes. Br J Psychiatry (1992) 0.76

The respiratory depressive effects of intravenous buprenorphine in patients in an intensive care unit. S Afr Med J (1979) 0.76

[Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain]. Wien Med Wochenschr (2003) 0.75